Disclosures for "Reduced Time to Treatment After Implementation of a Standardized Guideline for the Diagnostic Evaluation and Acute Management of Suspected Autoimmune Encephalitis in Hospitalized Adult Patients"
-
Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
-
Mr. Steuart has nothing to disclose.
-
Dr. Rajarajan has nothing to disclose.
-
Miss Leles Vieira de Souza has nothing to disclose.
-
Dr. Rodin has nothing to disclose.
-
Dr. Rettenmaier has nothing to disclose.
-
Dr. McEntire has nothing to disclose.
-
Dr. Mashlah has nothing to disclose.
-
Dr. Bilodeau has nothing to disclose.
-
Dr. Wibecan has nothing to disclose.
-
Dr. Linnoila has received research support from NIH/NINDS. Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/vaccine injury compensation program.